AC
BIIB icon

AFAM Capital’s Biogen BIIB Stock Holding History

AFAM Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$6.28M Buy
17,777
+321
+2% +$111K 0.87% 42
2018
Q2 		$5.07M Sell
17,456
-60
-0.3% -$16.9K 0.74% 61
2018
Q1 		$4.8M Buy
17,516
+216
+1% +$67K 0.53% 90
2017
Q4 		$5.51M Buy
17,300
+227
+1% +$72.8K 0.61% 75
2017
Q3 		$5.35M Buy
17,073
+18
+0.1% +$5.33K 0.65% 69
2017
Q2 		$4.63M Sell
17,055
-6
-0% -$1.59K 0.59% 76
2017
Q1 		$4.67M Buy
17,061
+127
+0.7% +$35.9K 0.65% 67
2016
Q4 		$4.8M Buy
16,934
+292
+2% +$86.6K 0.73% 58
2016
Q3 		$5.21M Sell
16,642
-189
-1% -$56K 0.83% 44
2016
Q2 		$4.07M Buy
16,831
+22
+0.1% +$5.8K 0.67% 68
2016
Q1 		$4.38M Sell
16,809
-580
-3% -$153K 0.71% 61
2015
Q4 		$5.33M Buy
+17,389
New +$5M 0.83% 46

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

AFAM Capital's BIIB Position: Q3 2018 in Review

AFAM Capital increased its Biogen (BIIB) stake by 1.8% in Q3 2018, buying an estimated $111K and bringing the position to 17,777 shares worth $6.28M. The position accounts for 0.87% of the portfolio, ranked #42.

AFAM Capital first reported a position in BIIB in Q4 2015 and has held it in 12 quarters since. 1,145 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

  • AFAM Capital held 17,777 shares of Biogen worth $6.28M as of Q3 2018.
  • AFAM Capital bought 321 Biogen shares in Q3 2018, an estimated $111K.
  • Biogen made up 0.87% of AFAM Capital's portfolio in Q3 2018, its #42 holding.
  • AFAM Capital first reported a position in Biogen in Q4 2015 and has held it in 12 quarters since.
  • 1,145 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on AFAM Capital's 13F filing for Q3 2018, filed 14 Nov 2018.